Forward Pharma A/S. Daily Stock Analysis

Daily Stock Analysis, FWP, Forward Pharma A/S, priceseries

Forward Pharma A/S. Daily Stock Analysis
Stock Information
Open
5.24
Close
5.33
High
5.39
Low
5.24
Previous Close
5.38
Daily Price Gain
-0.05
YTD High
6.48
YTD High Date
Jan 6, 2022
YTD Low
5.05
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.81
YTD Gain
-13.27%
52 Week High
20.31
52 Week High Date
Jul 21, 2021
52 Week Low
5.05
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-1.50
52 Week Gain
-22.04%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 4. 2017
112.42
Feb 3. 2017
199.17
21 Trading Days
77.17%
Link
LONG
Jul 19. 2017
151.03
Aug 22. 2017
168.80
24 Trading Days
11.77%
Link
LONG
Jan 24. 2018
32.20
Jan 29. 2018
35.71
3 Trading Days
10.89%
Link
LONG
Nov 7. 2018
11.97
Nov 8. 2018
13.61
1 Trading Days
13.68%
Link
LONG
Feb 4. 2019
8.40
Feb 11. 2019
8.98
5 Trading Days
6.88%
Link
LONG
Mar 31. 2020
5.62
Apr 1. 2020
5.90
1 Trading Days
5.08%
Link
LONG
May 8. 2020
7.27
May 13. 2020
10.00
3 Trading Days
37.48%
Link
LONG
Jun 10. 2021
7.90
Jun 11. 2021
8.32
1 Trading Days
5.38%
Link
LONG
Jul 9. 2021
8.28
Jul 29. 2021
12.98
14 Trading Days
56.77%
Link
Company Information
Stock Symbol
FWP
Exchange
NasdaqGS
Company URL
http://www.forward-pharma.com
Company Phone
0114533444242
CEO
Claus Bo Svendsen
Headquarters
-
Business Address
OSTERGADE 24A, 1, COPENHAGEN, DENMARK 1100
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001604924
About

Forward Pharma is a biopharmaceutical company which engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate (DMF) and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.

Description

Forward Pharma A/S operates as a biopharmaceutical company. The company engages in developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading